These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19147071)

  • 61. Infant acute bilineal leukemia.
    Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
    Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients.
    Sperotto A; Damiani D; Zaja F; Patriarca F; Geromin A; Cerno M; Stocchi R; Tiribelli M; Skert C; Rinaldi C; Fanin R
    Adv Clin Path; 2002 Apr; 6(2):77-85. PubMed ID: 19753729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.
    Saraceni F; Bruno B; Lemoli RM; Meloni G; Arcese W; Falda M; Ciceri F; Alessandrino EP; Specchia G; Scimè R; Raimondi R; Bacigalupo A; Bosi A; Onida F; Rambaldi A; Bonifazi F; Olivieri A
    Bone Marrow Transplant; 2017 Jan; 52(1):163-166. PubMed ID: 27668760
    [No Abstract]   [Full Text] [Related]  

  • 65. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
    Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
    [No Abstract]   [Full Text] [Related]  

  • 66. [Current treatment of acute myeloid leukemia].
    Ohtake S
    Rinsho Ketsueki; 2012 Oct; 53(10):1560-70. PubMed ID: 23037728
    [No Abstract]   [Full Text] [Related]  

  • 67. Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
    Ferrara F; Mele G; Palmieri S; Pedata M; Copia C; Riccardi C; Izzo T; Criscuolo C; Musto P
    Hematol Oncol; 2009 Dec; 27(4):198-202. PubMed ID: 19475701
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The stem cell transplant program in Pakistan--the first decade.
    Shamsi Ts; Hashmi K; Adil S; Ahmad P; Irfan M; Raza S; Masood N; Shaikh U; Satti T; Farzana T; Ansari S
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S114-S117. PubMed ID: 18724282
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
    Ferrara F; Palmieri S; Pedata M; Viola A; Izzo T; Criscuolo C; Mele G
    Hematol Oncol; 2009 Mar; 27(1):40-5. PubMed ID: 19206083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
    Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?
    Dombret H; Preudhomme C; Boissel N
    Curr Opin Hematol; 2009 Mar; 16(2):92-7. PubMed ID: 19468270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives.
    Sekeres MA
    Haematologica; 2008 Dec; 93(12):1769-72. PubMed ID: 19050066
    [No Abstract]   [Full Text] [Related]  

  • 74. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.
    Babatunde AS; Tan DC; Heng KK; Lee JJ; Loh YS; Hwang WY; Koh MB; Goh YT; Linn YC
    Bone Marrow Transplant; 2009 Aug; 44(3):175-83. PubMed ID: 19204715
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donor.
    Zeiser R; Zerweck A; Bertz H; Finke J
    Bone Marrow Transplant; 2009 Apr; 43(7):589-90. PubMed ID: 18978821
    [No Abstract]   [Full Text] [Related]  

  • 77. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Xu LP; Luo XH; Chang YJ; Liu DH; Liu KY; Chen YH; Huang XJ
    Ann Hematol; 2009 Oct; 88(10):1015-24. PubMed ID: 19319533
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.
    Megged O; Shalit I; Yaniv I; Stein J; Fisher S; Levy I
    Pediatr Transplant; 2008 Dec; 12(8):902-5. PubMed ID: 18194354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
    Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
    Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.